Sensitivity to the MEK inhibitor E6201 in melanoma cells is associated with mutant BRAF and wildtype PTEN status
Sara A. Byron(Translational Genomics Research Institute), Pamela M. Pollock(Queensland University of Technology)
Cited by 45
Related Papers
Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells
|British Journal of Cancer|2006|118
Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma
|Molecular Cancer Research|2009|118
PI3K Inhibitors Synergize with FGFR Inhibitors to Enhance Antitumor Responses in FGFR2mutant Endometrial Cancers
|Molecular Cancer Therapeutics|2017|51
FGFR2-activating mutations disrupt cell polarity to potentiate migration and invasion in endometrial cancer cell models
|Journal of Cell Science|2018|25